Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced the presentation of interim data from the C-SWIFT study
exploring the potential of a candidate triple-therapy regimen consisting
of the fixed-dose combination of grazoprevir/elbasvir (MK-5172/MK-8742,
MK-5172A), the company’s investigational NS3/4A protease inhibitor and
NS5A inhibitor, in combination with sofosbuvir, a nucleotide (NS5B)
inhibitor for the treatment of chronic hepatitis C virus (HCV)
Sign-up for Interim Data from Proof-of-Concept Study of Merck’s Investigational Hepatitis C Treatment Grazoprevir/Elbasvir in Combination with a Nucleotide Inhibitor (C-SWIFT study) Presented at The Liver Meeting® investment picks
At its annual investor conference being held today, Xerox
(NYSE:XRX) is updating progress on its strategy with a focus on
delivering long-term value for shareholders through earnings expansion,
leading innovation and a diversified portfolio.
Sign-up for Flushing Financial Corporation Reports 12% Increase in Core Diluted EPS From Prior Year Comparable Quarter, Driven by Improved Credit Metrics and a 29.8% Increase in Loan Originations From the Trailing Quarter investment picks
A video with images of home that included backyard barbecues, relaxing
and playing music with her Boston terrier – all set to a toe-tapping
tune – propelled newlywed Leslie Poprik of Ardmore, Pennsylvania to win
$250,000 in the Wells
Fargo (NYSE: WFC) “What Makes a Home” contest.
- John Hancock Investor Sentiment Index shows 70% of investors with children or grandchildren plan to contribute to their college education and 62% have started saving
- But only 24% own a 529 college savings plan, though 55% believe it is a good time to invest in one BOSTON , Dec.
SciFluor Life Sciences, LLC, an emerging clinical stage
biopharmaceutical company that creates innovative therapeutics for
patients with ophthalmologic and neurologic disease, announced today
that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent
Interactive Brokers Group, Inc. (NASDAQ GS:IBKR) plans to announce its
fourth quarter financial results on Tuesday, January 20, 2015, in a
release that will be issued at approximately 4:00 pm (ET). The press
release will also be available on the company's web site, www.interactivebrokers.com/ir .
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.